|
|
|
| Genetic characteristics of the VP1 coding region of poliovirus in Anhui Province |
| HE Jiali, CHENG Xiaodong, WANG Xin, WANG Binbing, SU Ying, CHENG Pengbo, SONG Feiyang, CHAI Yu
|
| Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui 230601, China |
|
|
|
|
Abstract Objective To analyze the serotypes and VP1 coding region genetic characteristics of poliovirus (PV) isolated from Acute Flaccid Paralysis (AFP) Surveillance System and environmental sewage surveillance samples in Anhui Province. Methods PV was isolated from fecal samples of polio cases and their close contacts in the AFP Surveillance System and environmental sewage surveillance samples in Anhui Province in 2023. Intratype identification was performed by rRT-PCR method. The nucleotide sequence variation sites and variation numbers in the VP1 coding region were amplified and determined. The mutation hotspots, neurovirulence determinants, and antigenic determinant site changes were analyzed. A PV phylogenetic tree was constructed based on the VP1 coding region gene, and the genetic association between PV in Anhui Province and other foreign vaccine-derived PV (VDPV) was analyzed. Results A total of 35 PV strains were isolated in Anhui Province in 2023, including 10 strains from AFP Surveillance System samples and 25 strains from environmental sewage surveillance samples. By intratype identification, there were 14 type Ⅰ PV strains and 21 type Ⅲ PV strains. By VDPV screening, there were 2 type Ⅰ VDPV strains, with VP1 coding region nucleotide sequence variation numbers of 10-<150; all others were vaccine-like strains. The mutation rates of nt2747 and nt2795 sites in type Ⅰ PV were higher, which were 78.57% and 21.43%, respectively. Three strains had revertant mutations at the attenuated site nt2795. Twelve strains had mutations at antigenic determinant site 1. The mutation rates of nt3353, nt3346, and nt3357 sites in type Ⅲ PV were higher, which were 42.86%, 28.57%, and 28.57%, respectively. No revertant mutations were found at attenuated sites. Four strains had mutations at antigenic determinant site 2, and 6 strains had mutations at antigenic determinant site 3. Phylogenetic tree analysis showed that the isolated 2 type Ⅰ VDPV strains were on the same independent main branch, which was different from other isolated type Ⅰ PV strains, and had a distant genetic relationship with other VDPV monitored abroad. Conclusions In 2023, the VP1 coding regions of type Ⅰ and type Ⅲ PV isolated in Anhui Province had mutation hotspots, and revertant mutations occurred at attenuated sites. Type Ⅰ VDPV had no genetic association with previously discovered VDPV. It is recommended to strengthen PV surveillance and sequence analysis capabilities to reduce the risk of circulating VDPV.
|
|
Received: 23 September 2025
Revised: 21 January 2026
Published: 11 February 2026
|
|
|
|
|
|
[1] 何佳丽,王斌冰,汪馨,等.安徽省2023年Ⅰ型疫苗衍生脊髓灰质炎病毒鉴定及其传播风险评估[J].安徽预防医学杂志,2024,30(1):43-46,78.
[2] 唐海淑,李晓嫘,凯塞尔·吾斯曼,等.2018年新疆维吾尔自治区外环境污水中分离到1株Ⅱ型疫苗衍生脊髓灰质炎病毒[J].中国疫苗和免疫,2019,25(4):368-372.
[3] LI J L,RODEWALD L E,ZHANG W,et al.Investigation and response to a type 3 vaccine-derived poliovirus detected in an infant with hand,foot,and mouth disease-Guangdong,China,2023[J/OL].J Health Popul Nutr,2025,44(1)[2026-01-21].https://doi.org/10.1186/s41043-025-00911-5.
[4] 陈美钟,张薇,黄淑芬,等.广东省1例原发性免疫缺陷患者排出的Ⅱ型疫苗衍生脊髓灰质炎病毒分子病毒学特征[J].中国疫苗和免疫,2022,28(3):263-267.
[5] 任丽萍,朱晖,邵玉平,等.辽宁省首株Ⅱ型疫苗衍生脊髓灰质炎病毒的鉴定及对中国维持无脊髓灰质炎的挑战[J].中国疫苗和免疫,2019,25(2):131-135.
[6] 汤晶晶,张杰,张筱碟,等.2021年云南省环境污水中检出1株疫苗衍生脊髓灰质炎病毒[J].病毒学报,2022,38(6):1289-1296.
[7] RAHARINANTOANINA J,JOFFRET M L,BESSAUD M,et al.Wide circulation of type 1 vaccine-derived poliovirus strains in clinical specimens from suspected cases of poliomyelitis,their contacts and in wastewater in Madagascar since late 2020[J/OL].Virology,2024,600[2026-01-21].https://doi.org/10.1016/j.virol.2024.110253.
[8] ZHANG M Y,YANG J H,BAI Y R,et al.Epidemiological survey and genetic characterization of type 3 vaccine-derived poliovirus isolated from a patient with four doses of inactivated polio vaccine in Henan Province,China[J/OL].Infect Dis Poverty,2022,11(1)[2026-01-21].https://doi.org/10.1186/s40249-022-01028-1.
[9] 安军静,朱晖,严冬梅,等.中国2009年Ⅰ型脊髓灰质炎病毒基因特征分析[J].中国疫苗和免疫,2010,16(2):115-121.
[10] 张波,严冬梅,祝双利,等.中国2011年Ⅲ型脊髓灰质炎病毒基因特征分析[J].中国疫苗和免疫,2015,21(1):19-23,54.
[11] LIU Y H,MA T F,LIU J Z,et al.Bioinformatics analysis and genetic diversity of the poliovirus[J].J Med Microbiol,2014,63(Pt 12):1724-1731.
[12] 张波,严冬梅,祝双利,等.中国2011年Ⅲ型脊髓灰质炎病毒基因特征分析[J].中国疫苗和免疫,2015,21(1):19-23,54.
[13] 张明瑜,杨建辉,路环环,等.2018年河南省肠道病毒环境监测结果分析[J].病毒学报,2021,37(5):1112-1118. |
|
|
|
